About Contact Privacy
Heart AI Safety Research
  • Home
  • Medical Insights
  • Preventive Care
  • Health News
  • Chronic Conditions
  • Nutrition
Home ›Medical Insights

Medical Insights

Breakthrough Device: Expedited Review, Not Investment Validation Medical Insights

Breakthrough Device: Expedited Review, Not Investment Validation

An FDA Breakthrough Device Designation is just a process signal, it flags an expedited review route.…

Editorial Team Nov 2, 2026 · 6 min read
Fairness: The $14.8 Billion Cardiac AI Imperative Medical Insights

Fairness: The $14.8 Billion Cardiac AI Imperative

When you’re evaluating a cardiac AI program, looking at the top-line outcomes isn’t enough. You have…

Editorial Team Nov 2, 2026 · 5 min read
Cardiologist Overrides: Unpacking AI’s Cardiac Efficacy & Bias Medical Insights

Cardiologist Overrides: Unpacking AI’s Cardiac Efficacy & Bias

Override rates in cardiac AI are the ultimate proof of a model’s real-world efficacy. It’s the…

Editorial Team Nov 2, 2026 · 6 min read
Cardiac AI: Navigating Post-Market Oversight for Investors Medical Insights

Cardiac AI: Navigating Post-Market Oversight for Investors

When you look at the FDA device record, one area jumps out: cardiac AI. It’s got…

Editorial Team Nov 2, 2026 · 4 min read
Cardiac AI: The Hidden Gap Between Clearance and Accuracy Medical Insights

Cardiac AI: The Hidden Gap Between Clearance and Accuracy

There’s a real gap between a cardiac AI vendor’s regulatory clearance claims and its measured accuracy…

Editorial Team Oct 30, 2026 · 6 min read
De Novo: Unlocking Cardiac AI’s Billion Dollar Market Potential Medical Insights

De Novo: Unlocking Cardiac AI’s Billion Dollar Market Potential

The FDA’s De Novo Classification process is the regulatory pathway for any truly novel medical device,…

Editorial Team Oct 30, 2026 · 6 min read
Decoding De Novo: What Cardiac AI Clearance *Really* Means for Investors Medical Insights

Decoding De Novo: What Cardiac AI Clearance *Really* Means for Investors

A regulatory clearance just marks the start of the real review, with the FDA’s recorded De…

Editorial Team Oct 29, 2026 · 5 min read
Cardiac AI: De-Risking Adaptive Models with Change Control Medical Insights

Cardiac AI: De-Risking Adaptive Models with Change Control

Cardiac AI Regulatory Safety frames model change as a regulatory question. When you’re dealing with a…

Editorial Team Oct 29, 2026 · 6 min read
Cardiac AI: De-Risking Investment Through Clinician Verification Medical Insights

Cardiac AI: De-Risking Investment Through Clinician Verification

The safety of a cardiac AI hinges on how its output actually gets used by a…

Editorial Team Oct 28, 2026 · 5 min read
Demographic Coverage: Unlocking Equitable Cardiac AI Medical Insights

Demographic Coverage: Unlocking Equitable Cardiac AI

Demographic coverage isn’t an academic idea. It’s a measurable property of an AI model’s validation evidence.…

Editorial Team Oct 28, 2026 · 5 min read

Posts pagination

‹ Previous 1 2 3 … 9 Next ›
Cardiac AI: Why Post-Market Surveillance is Your Next Big Bet

Cardiac AI: Why Post-Market Surveillance is Your Next Big Bet

Nov 6 · 5 min read
Mayo Standard: De-Risking AI Cardiac Investment & Proving ROI

Mayo Standard: De-Risking AI Cardiac Investment & Proving ROI

Nov 6 · 5 min read
Theranos to Olive AI: What Validation Theater Costs Cardiac AI

Theranos to Olive AI: What Validation Theater Costs Cardiac AI

Nov 5 · 5 min read
Cardiac AI Fairness: The Billion-Dollar Equity Question

Cardiac AI Fairness: The Billion-Dollar Equity Question

Nov 5 · 5 min read
Ultromics’ FDA Breakthrough: Single-Image AI for Heart Failure

Ultromics’ FDA Breakthrough: Single-Image AI for Heart Failure

Jul 13 · 6 min read
Cardiac AI Safety: FDA Clearances & Evidence Depth Compared

Cardiac AI Safety: FDA Clearances & Evidence Depth Compared

Jul 15 · 8 min read
Butterfly Network: AI Ultrasound’s Safe Path to 14 Billion Dollar Cardiac Market

Butterfly Network: AI Ultrasound’s Safe Path to 14 Billion Dollar Cardiac Market

Jul 15 · 6 min read
Cardiac AI’s 11% Problem: Why Innovation Lags in a Billion-Dollar Market

Cardiac AI’s 11% Problem: Why Innovation Lags in a Billion-Dollar Market

Jul 13 · 6 min read
Most Viewed
Ultromics’ FDA Breakthrough: Single-Image AI for Heart Failure Medical Insights

Ultromics’ FDA Breakthrough: Single-Image AI for Heart Failure

Ultromics’ EchoGo HF, an AI system designed to detect heart failure from a single echocardiogram image,…

Editorial Team Jul 13, 2026 · 6 min read
Subscribe

Newsletter

Get Latest Updates

Categories
  • Medical Insights89
  • Preventive Care11
  • Health News9
  • Chronic Conditions4
  • Nutrition3
  • Mental Well-being3
  • Fitness1

Ready to dive in?

Expert insights, guides, and stories about health

Categories

  • Medical Insights
  • Preventive Care
  • Health News
  • Chronic Conditions

Quick Links

  • About
  • Contact
  • Privacy Policy
  • Terms of Service

Explore

  • Nutrition
  • Mental Well-being
  • Fitness
Stay up to date

Get notified when I publish something new, and unsubscribe at any time.

©2026 Heart AI Safety Research. All rights reserved.